Free Trial
Fall Lock-In Sale! MarketBeat All Access, $149 a Year for Life
Lock In $149
Claim MarketBeat All Access Sale Promotion

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Compare
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Chemed Corporation stock logo
CHE
Chemed
$519.44
+1.3%		$514.99
$365.20
▼
$557.00
$6.80B0.51200,799 shs18,031 shs
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
$27.54
-0.6%		$29.12
$13.74
▼
$50.19
$6.43B2.4422.57 million shs1.25 million shs
RadNet, Inc. stock logo
RDNT
RadNet
$71.07
+1.0%		$72.80
$50.82
▼
$85.84
$5.60B1.41781,035 shs22,118 shs
GeneDx Holdings Corp. stock logo
WGS
GeneDx
$61.35
+9.3%		$80.50
$32.21
▼
$170.87
$1.83B1.95921,740 shs224,308 shs
The 7 Hottest IPO Stories of 2026 Cover
The 7 Hottest IPO Stories of 2026

MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Chemed Corporation stock logo
CHE
Chemed
0.00%+0.10%-0.03%+0.87%+17.65%
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
0.00%-1.34%-5.98%-8.37%-43.31%
RadNet, Inc. stock logo
RDNT
RadNet
0.00%+2.24%-0.64%+14.36%-15.67%
GeneDx Holdings Corp. stock logo
WGS
GeneDx
0.00%-11.73%-36.48%-7.25%-56.43%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Chemed Corporation stock logo
CHE
Chemed
$519.44
+1.3%		$514.99
$365.20
▼
$557.00
$6.80B0.51200,799 shs18,031 shs
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
$27.54
-0.6%		$29.12
$13.74
▼
$50.19
$6.43B2.4422.57 million shs1.25 million shs
RadNet, Inc. stock logo
RDNT
RadNet
$71.07
+1.0%		$72.80
$50.82
▼
$85.84
$5.60B1.41781,035 shs22,118 shs
GeneDx Holdings Corp. stock logo
WGS
GeneDx
$61.35
+9.3%		$80.50
$32.21
▼
$170.87
$1.83B1.95921,740 shs224,308 shs
The 7 Hottest IPO Stories of 2026 Cover
The 7 Hottest IPO Stories of 2026

MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Chemed Corporation stock logo
CHE
Chemed
0.00%+0.10%-0.03%+0.87%+17.65%
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
0.00%-1.34%-5.98%-8.37%-43.31%
RadNet, Inc. stock logo
RDNT
RadNet
0.00%+2.24%-0.64%+14.36%-15.67%
GeneDx Holdings Corp. stock logo
WGS
GeneDx
0.00%-11.73%-36.48%-7.25%-56.43%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Chemed Corporation stock logo
CHE
Chemed
2.29
Hold$554.606.77% Upside
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
2.13
Hold$32.4317.79% Upside
RadNet, Inc. stock logo
RDNT
RadNet
3.11
Buy$90.0026.63% Upside
GeneDx Holdings Corp. stock logo
WGS
GeneDx
2.67
Moderate Buy$90.8648.09% Upside

Current Analyst Ratings Breakdown

Latest WGS, HIMS, CHE, and RDNT Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
10/9/2026
RadNet, Inc. stock logo
RDNT
RadNet
Zacks Research logo
Zacks Research
Subscribe to MarketBeat All Access to unlock brokerage rankings
UpgradeHold ➝ Strong-Buy
10/9/2026
GeneDx Holdings Corp. stock logo
WGS
GeneDx
Zacks Research logo
Zacks Research
Subscribe to MarketBeat All Access to unlock brokerage rankings
DowngradeStrong-Buy ➝ Hold
10/8/2026
Chemed Corporation stock logo
CHE
Chemed
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access to unlock brokerage rankings
UpgradeHold (C) ➝ Hold (C+)
10/1/2026
GeneDx Holdings Corp. stock logo
WGS
GeneDx
Guggenheim logo
Guggenheim
Subscribe to MarketBeat All Access to unlock brokerage rankings
Boost Price TargetBuy$74.00 ➝ $83.00
9/25/2026
Chemed Corporation stock logo
CHE
Chemed
UBS Group AG logo
UBS Group
Subscribe to MarketBeat All Access to unlock brokerage rankings
Initiated CoverageBuy$650.00
9/25/2026
Chemed Corporation stock logo
CHE
Chemed
UBS Group AG logo
UBS Group
Subscribe to MarketBeat All Access to unlock brokerage rankings
Initiated CoverageBuy$650.00
9/25/2026
Chemed Corporation stock logo
CHE
Chemed
UBS Group AG logo
UBS Group
Subscribe to MarketBeat All Access to unlock brokerage rankings
Initiated CoverageBuy$650.00
9/22/2026
RadNet, Inc. stock logo
RDNT
RadNet
Raymond James Financial, Inc. logo
Raymond James Financial
Subscribe to MarketBeat All Access to unlock brokerage rankings
Reiterated RatingStrong-Buy
9/11/2026
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
JPMorgan Chase & Co. logo
JPMorgan Chase & Co.
Subscribe to MarketBeat All Access to unlock brokerage rankings
Initiated CoverageNeutral$32.00
8/28/2026
RadNet, Inc. stock logo
RDNT
RadNet
Barclays PLC logo
Barclays
Subscribe to MarketBeat All Access to unlock brokerage rankings
Boost Price TargetOverweight$65.00 ➝ $79.00
8/26/2026
GeneDx Holdings Corp. stock logo
WGS
GeneDx
Zacks Research logo
Zacks Research
Subscribe to MarketBeat All Access to unlock brokerage rankings
UpgradeHold ➝ Strong-Buy
(Data available from 10/26/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Chemed Corporation stock logo
CHE
Chemed
$2.53B2.68$24.97 per share20.80$69.15 per share7.51
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
$2.35B2.74$0.83 per share33.11$2.38 per share11.57
RadNet, Inc. stock logo
RDNT
RadNet
$2.04B2.74$3.26 per share21.82$17.58 per share4.04
GeneDx Holdings Corp. stock logo
WGS
GeneDx
$427.54M4.28$2.50 per share24.50$10.54 per share5.82
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Chemed Corporation stock logo
CHE
Chemed
$265.24M$19.9126.1220.642.0610.60%31.77%18.90%10/27/2026 (Estimated)
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
$128.37M-$0.63N/A62.58N/A-5.51%-6.51%-1.20%11/9/2026 (Estimated)
RadNet, Inc. stock logo
RDNT
RadNet
-$18.65M-$0.27N/A81.69N/A-0.93%2.61%0.91%11/9/2026 (Estimated)
GeneDx Holdings Corp. stock logo
WGS
GeneDx
-$21.02M-$3.64N/A53.35N/A-23.41%4.12%2.26%11/9/2026 (Confirmed)

Latest WGS, HIMS, CHE, and RDNT Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
11/9/2026Q3 2026
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
$0.0566N/AN/AN/A$892.88 millionN/A
11/9/2026Q3 2026
RadNet, Inc. stock logo
RDNT
RadNet
$0.2214N/AN/AN/A$639.97 millionN/A
11/3/2026Q3 2026
GeneDx Holdings Corp. stock logo
WGS
GeneDx
$0.0729N/AN/AN/A$122.93 millionN/A
10/27/2026Q3 2026
Chemed Corporation stock logo
CHE
Chemed
$6.39N/AN/AN/A$685.04 millionN/A
8/10/2026Q2 2026
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
-$0.0498-$0.37-$0.3202-$0.37$698.90 million$753.21 million
8/10/2026Q2 2026
RadNet, Inc. stock logo
RDNT
RadNet
$0.2014$0.29+$0.0886$0.10$610.87 million$622.72 million
8/3/2026Q2 2026
GeneDx Holdings Corp. stock logo
WGS
GeneDx
-$0.1879$0.01+$0.1979-$0.60$111.01 million$114.44 million
7/28/2026Q2 2026
Chemed Corporation stock logo
CHE
Chemed
$5.60$6.06+$0.46$5.13$665.04 million$673.25 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Chemed Corporation stock logo
CHE
Chemed
$2.800.54%+10.76%14.06%16 Years
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
N/AN/AN/AN/AN/A
RadNet, Inc. stock logo
RDNT
RadNet
N/AN/AN/AN/AN/A
GeneDx Holdings Corp. stock logo
WGS
GeneDx
N/AN/AN/AN/AN/A

Latest WGS, HIMS, CHE, and RDNT Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
8/6/2026
Chemed Corporation stock logo
CHE
Chemed
quarterly$0.700.53%8/17/20268/17/20269/3/2026
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Chemed Corporation stock logo
CHE
Chemed
0.17
0.91
0.89
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
4.21
0.93
0.87
RadNet, Inc. stock logo
RDNT
RadNet
0.94
1.48
1.48
GeneDx Holdings Corp. stock logo
WGS
GeneDx
0.40
3.30
3.06

Institutional Ownership

CompanyInstitutional Ownership
Chemed Corporation stock logo
CHE
Chemed
95.85%
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
63.52%
RadNet, Inc. stock logo
RDNT
RadNet
77.90%
GeneDx Holdings Corp. stock logo
WGS
GeneDx
61.72%

Insider Ownership

CompanyInsider Ownership
Chemed Corporation stock logo
CHE
Chemed
3.33%
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
11.76%
RadNet, Inc. stock logo
RDNT
RadNet
5.14%
GeneDx Holdings Corp. stock logo
WGS
GeneDx
25.17%
CompanyEmployeesShares OutstandingFree FloatOptionable
Chemed Corporation stock logo
CHE
Chemed
15,81113.07 million12.64 millionOptionable
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
2,442233.31 million205.88 millionOptionable
RadNet, Inc. stock logo
RDNT
RadNet
11,26478.70 million74.65 millionOptionable
GeneDx Holdings Corp. stock logo
WGS
GeneDx
1,30029.82 million22.32 millionOptionable

Recent News About These Companies

GeneDx (NASDAQ:WGS) Shares Down 7.7% - Should You Sell?
October 25 at 4:21 AM  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31155372
Why GeneDx Holdings Corp.’s (WGS) Stock Is Down 11.26%
October 23 at 7:48 PM  |  aaii.comA
GeneDx to Report Third Quarter 2026 Financial Results on Monday, November 9, 2026
October 23 at 4:05 PM  |  businesswire.comhttps://www.businesswire.com/news/home/20261023746780/en/genedx-to-report-third-quarter-2026-financial-results-on-monday-november-9-2026/
GeneDx (NASDAQ:WGS) Shares Down 7.7% - What's Next?
October 23 at 1:59 PM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/price-genedx-nasdaq-wgs-shares-down-77-whats-next-2026-10-23/
AdaptHealth (NASDAQ:AHCO) versus GeneDx (NASDAQ:WGS) Financial Contrast
October 22, 2026  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31145993
GeneDx to Add Long-Read Whole Genome Sequencing to Testing Portfolio
October 20, 2026  |  marketscreener.comM
GeneDx Expands Diagnostic Leadership with Long-Read Genome Sequencing, Advancing Rare Disease Diagnosis
October 20, 2026  |  businesswire.comhttps://www.businesswire.com/news/home/20261020061134/en/GeneDx-Expands-Diagnostic-Leadership-with-Long-Read-Genome-Sequencing-Advancing-Rare-Disease-Diagnosis
GeneDx Holdings Corp. Advances Clinical Adoption of Genomic Medicine with 27 Abstracts at ASHG 2026
October 20, 2026  |  marketscreener.comM
GeneDx (WGS) Projected to Announce Quarterly Earnings on Tuesday
October 20, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/upcoming-genedx-wgs-projected-to-announce-quarterly-earnings-on-tuesday-2026-10-20/
GeneDx Advances Clinical Adoption of Genomic Medicine with 27 Abstracts at ASHG 2026
October 19, 2026  |  businesswire.comhttps://www.businesswire.com/news/home/20261019110025/en/genedx-advances-clinical-adoption-of-genomic-medicine-with-27-abstracts-at-ashg-2026/
GeneDx (NASDAQ:WGS) Stock Falls 5.5% – Here’s What Happened
October 18, 2026  |  defenseworld.netD
GeneDx Holdings Corp. $WGS Shares Acquired by Assenagon Asset Management S.A.
October 18, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-genedx-holdings-corp-wgs-shares-acquired-by-assenagon-asset-management-sa-2026-10-18/
GeneDx Holdings And 2 Other Top Healthcare Stocks
October 17, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/healthcare/articles/genedx-holdings-2-other-top-151153865.html
GeneDx (NASDAQ:WGS) Shares Down 5.5% - What's Next?
October 16, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/price-genedx-nasdaq-wgs-shares-down-55-whats-next-2026-10-16/
GeneDx (NASDAQ:WGS) Shares Climb 3.8% - Here's What Happened
October 14, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/price-genedx-nasdaq-wgs-shares-climb-38-heres-what-happened-2026-10-14/
GeneDx Holdings Corp. (NASDAQ:WGS) Stock Has Average Target Price of $90.86
October 11, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/consensus-genedx-holdings-corp-nasdaq-wgs-stock-has-average-target-price-of-9086-2026-10-11/
Top 3 Healthcare Stocks To Watch In October 2026
October 10, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/healthcare/articles/top-3-healthcare-stocks-watch-141730151.html
GeneDx Presents New Evidence Advancing Genomic Newborn Screening at ICoNS 2026
October 7, 2026  |  marketscreener.comM
GeneDx (NASDAQ:WGS) Stock Price Down 6.1% - What's Next?
October 6, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/price-genedx-nasdaq-wgs-stock-price-down-61-whats-next-2026-10-06/
GeneDx Holdings Corp (WGS) Shares Surge 4.3% -- What GF Score of 67 Tells Investors
October 5, 2026  |  gurufocus.comhttps://www.gurufocus.com/news/9110528/genedx-holdings-corp-wgs-shares-surge-43-what-gf-score-of-67-tells-investors
GeneDx Introduces Easy Order at AAP 2026 to Simplify Genomic Testing in Everyday Pediatric Care
October 2, 2026  |  businesswire.comhttps://www.businesswire.com/news/home/20261001771109/en/genedx-introduces-easy-order-at-aap-2026-to-simplify-genomic-testing-in-everyday-pediatric-care/

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Television displaying the Netflix logo in a dark living room with a coffee table, popcorn bowl, and remote.
Deutsche Bank Makes a Contrarian Call on Netflix—What Does It Mean for Investors?
By Sam Quirke | September 30, 2026
DraftKings logo displayed with a football, basketball, and poker chips on a dark sportsbook-themed background.
DraftKings Stacks the Deck: The $800M Prediction Pivot
By Jeffrey Neal Johnson | October 7, 2026
Six Flags logo displayed over a roller coaster and lake at sunset in an amusement park setting.
Six Flags Launches FlexPay—Is There Any FUN Left in the Stock?
By Chris Markoch | September 28, 2026
Illuminated Tesla logo in a factory setting with robotic machinery and a semiconductor wafer in the foreground.
Tesla Wants to Make Its Own Chips—What Could Go Wrong?
By Sam Quirke | October 14, 2026
Glass-walled office building lobby at sunset with a city skyline reflected in the exterior facade.
Data Centers Got the AI Hype—But Office REITs May Get the Rent Hikes
By Chris Markoch | September 27, 2026
Chemed stock logo

Chemed NYSE:CHE

$519.44 +6.46 (+1.26%)
As of 10:41 AM Eastern
This is a fair market value price provided by Massive. Learn more.

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees. The company was incorporated in 1970 and is headquartered in Cincinnati, Ohio.

Hims & Hers Health stock logo

Hims & Hers Health NYSE:HIMS

$27.49 -0.22 (-0.79%)
As of 10:41 AM Eastern
This is a fair market value price provided by Massive. Learn more.

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

RadNet stock logo

RadNet NASDAQ:RDNT

$71.07 +0.73 (+1.04%)
As of 10:41 AM Eastern
This is a fair market value price provided by Massive. Learn more.

RadNet, Inc., together with its subsidiaries, provides outpatient diagnostic imaging services in the United States. The company operates in two segments: Imaging Centers and Artificial Intelligence. Its services include magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, diagnostic radiology, fluoroscopy, and other related procedures, as well as multi-modality imaging services. The company also develops and sells computerized systems that distribute, display, store, and retrieve digital images; offers picture archiving communications systems and related services; and develops and deploys AI suites to enhance radiologist interpretation of breast, lung, and prostate images, as well as AI solutions for prostate cancer screening. RadNet, Inc. was founded in 1981 and is headquartered in Los Angeles, California.

GeneDx stock logo

GeneDx NASDAQ:WGS

$61.36 +5.21 (+9.27%)
As of 10:41 AM Eastern
This is a fair market value price provided by Massive. Learn more.

GeneDx Holdings Corp., through its subsidiaries, provides genomics-related diagnostic and information services. The company offers Centrellis, an AI-driven health intelligence platform that integrates digital tools and artificial intelligence allowing scientists to ingest and synthesize clinical and genomic data to deliver comprehensive health insights. It provides genetic diagnostic tests, screening solutions, and information with a focus on pediatrics, rare diseases for children and adults, and hereditary cancer screening. GeneDx Holdings Corp. was founded in 2017 and is headquartered in Stamford, Connecticut.

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

Stock Lists
Low Priced Stocks
Stocks By Exchange
Latest Stock Ideas